Venture Map · Round

Arthex Biotech — Series A · €4.25M

Announced 2020-07-23 · Valencia · Biotech

Arthex is a preclinical biotech developing antisense RNA therapies for myotonic dystrophy type 1. Invivo Ventures and Advent France Biotechnology co-led this €4.25M round. It follows a €2.7M seed from Invivo and CDTI-Innvierte, bringing the total raised to €6.95M.

RoundSeries A Amount€4.25M LeadNot disclosed Date2020-07-23 CityValencia SectorBiotech

Source article ↗ · www.arthexbiotech.com ↗

The company

ARTHEx Biotech

arthexbiotech.com

Company Series B Valencia

Investors 2

Advent France Biotechnology

www.adventfrancebiotechnology.com ↗

InvestorFrance